After a citalopram (Celexa) dose is reduced or stopped, new symptoms can be hard to interpret: are they discontinuation effects, a return of depression, or something else? Timing and symptom pattern can help a clinician investigate, but neither an online checklist nor one symptom can make the diagnosis.
Contact the prescriber before changing or stopping citalopram. The FDA-approved label advises gradual dose reduction when possible and monitoring for symptoms during a change. If you already stopped or missed doses, tell the clinician when and what symptoms began; do not double or restart without instructions. Suicidal thoughts or immediate danger require urgent help.
People often search “Celexa withdrawal vs relapse” after feeling dizzy, anxious, nauseated, unusually emotional, or unable to sleep following a dose change. The overlap can be frightening. A person may worry that the original depression is returning, or they may be told that every symptom is withdrawal. Neither conclusion should be made from timing alone.
Celexa is a brand name for citalopram, a selective serotonin reuptake inhibitor (SSRI). When an SSRI is reduced or stopped, some people experience discontinuation symptoms. Depression can also return, sometimes while a person is tapering or after stopping. Another medical issue or medicine effect may explain the change. These possibilities can overlap, and a clinician needs the full history to sort them out.
What discontinuation symptoms may feel like
Medication information for citalopram and SSRI labeling describes symptoms that may occur after stopping or reducing treatment. They can include dizziness, nausea, headache, sweating, irritability, anxiety, agitation, sleep disturbance, sensory changes, or flu-like feelings. Some people describe “electric shock” sensations or unusual tingling. Symptoms vary and are not a precise test for discontinuation.
Discontinuation symptoms can appear after a dose change, especially when a medicine is stopped abruptly, but the timing is not identical for everyone. The citalopram label and clinical guidance recommend gradual reduction when discontinuation is planned and monitoring for symptoms. The safest schedule is individualized; this article does not provide a taper calendar.
What a depressive relapse may look like
A return of depression may involve the symptoms that led to treatment or another change in mood and functioning: persistent low mood, loss of interest, hopelessness, changes in sleep or appetite, difficulty concentrating, low energy, withdrawal from relationships, or trouble completing ordinary tasks. Not every relapse looks the same, and people may have physical symptoms too.
Discontinuation effects and depression can overlap. Anxiety, sleep disruption, and low mood may occur in more than one situation. A person can experience withdrawal symptoms and a return of depression at the same time. Symptoms may also relate to stress, grief, illness, another medicine, or an ongoing diagnosis that needs reassessment.
| Clue to record | Why it may help | What it cannot prove |
|---|---|---|
| When symptoms began relative to a dose change | Timing may help the clinician consider discontinuation effects. | Timing alone does not establish the cause. |
| Which symptoms are new and which resemble the original depression | Pattern and history help compare current symptoms with prior episodes. | Overlap means one list cannot diagnose withdrawal or relapse. |
| Changes in sleep, appetite, activity, or ability to function | These details show how the change affects daily life. | Function changes can also have medical or situational causes. |
| Recent medicines, illness, stressors, or missed doses | Other factors can contribute or interact with the medication change. | A new factor does not automatically rule out relapse or discontinuation. |
| Thoughts of self-harm, feeling unsafe, or inability to care for yourself | These indicate the need for urgent support and safety planning. | Do not wait for a medication appointment to seek help. |
The timeline is a conversation tool, not a home diagnostic instrument. A person should not be told to ignore serious mood changes because the symptom started during a taper, and should not assume a relapse means the medicine must automatically be restarted. The prescriber can assess the pattern and discuss next steps.
Why abrupt changes create confusion
Stopping suddenly can cause uncomfortable physical or emotional symptoms and can make it difficult to tell whether the underlying condition is changing. A gradual plan gives the clinician a chance to monitor symptoms and respond if the person feels unwell. It can also reduce the risk of a person changing multiple variables at once, such as stopping citalopram while starting a supplement or another medicine.
Do not cut tablets, skip days, or take an every-other-day schedule unless the prescriber has specifically instructed that plan for the product you have. Citalopram tablets and liquid forms may have different practical instructions. If a dose was missed, follow the pharmacy leaflet or ask a pharmacist; do not double the next dose to compensate.
If you want to stop because of side effects, tell the prescriber what is happening and how severe it is. Some effects may need urgent review. A clinician can discuss alternatives or a planned change. If you are experiencing severe allergic symptoms, fainting, severe confusion, or another emergency, use urgent medical care rather than waiting for an office callback.
How to prepare for the appointment
A simple note can help: medication name and formulation; dose before and after the change; dates of missed or reduced doses; symptoms and when they began; sleep, appetite, and functioning; and any new medicine, alcohol, illness, or major stressor. You do not need a perfect diary. A few concrete examples are more useful than trying to remember everything under pressure.
- Describe the reason for the change. Was it planned, due to side effects, or caused by a refill gap?
- Separate physical and mood symptoms. Mention both, even if one seems more obvious.
- Explain the effect on daily life. Include work, caregiving, sleep, and social contact.
- Bring all medicines and supplements. Include occasional products and any recent starts or stops.
- Ask who to contact if symptoms worsen. Get an after-hours plan in writing.
If anxiety or low mood makes the appointment difficult, consider bringing a trusted support person if you want. They can help remember the clinician’s instructions, but you remain the decision-maker. If you prefer privacy, ask the office for a confidential conversation.
When to get urgent help
If you are thinking about suicide, harming yourself, or feel you may not be able to stay safe, call or text 988 in the United States for the Suicide & Crisis Lifeline, go to an emergency department, or call 911 if there is immediate danger. If possible, tell a trusted person and do not stay alone while waiting for help. If you are outside the United States, contact your local emergency or crisis service.
Urgent clinician contact is also appropriate if mood changes become severe, you cannot manage basic care, or you develop unusual agitation or behavior. New symptoms after a dose change should be reported, not hidden out of fear that the clinician will insist on restarting the same medication.
Questions to ask the prescriber
- Could this symptom pattern fit discontinuation, depression returning, another condition, or more than one cause?
- Should I continue the current plan or pause any further change while we assess it?
- What is the safest plan if I missed doses or ran out?
- Which symptoms mean I should call the same day or seek emergency support?
- How will we track mood and functioning during any future change?
- Who is available after hours if the symptoms worsen?
For additional context on common adverse effects, see our existing Celexa side-effects guide. A medicine’s side-effect page and a discontinuation plan answer different questions. Do not treat another drug’s stopping advice—such as our prednisolone guide—as instructions for citalopram.
How clinicians think through the difference
A clinician may compare the timing of the change, the person’s earlier depression symptoms, the current symptom mix, and how daily functioning has shifted. They may ask whether the medicine was tapered, whether doses were missed, and whether anything else changed. There is no blood test that cleanly labels every new feeling as “withdrawal” or “relapse,” and the two can occur together.
That uncertainty is not a reason to dismiss symptoms. It is a reason to report them accurately and keep follow-up close enough to respond. If the clinician recommends monitoring, ask what to record and when to call sooner. If the symptoms are becoming worse, do not wait until the next routine appointment just because a diary is incomplete.
Family or friends may notice changes in sleep, speech, interest, or self-care before the person does. If you want, bring someone who knows you well and ask them to share observations. Their perspective can help, but it should not replace your own account or your consent about who participates in care.
Do not treat online taper anecdotes as instructions
People may post that they stopped citalopram quickly without problems or that a particular reduction caused weeks of symptoms. These experiences can validate that others have struggled, but they do not reveal the poster’s dose, duration, other diagnoses, or support plan. The same schedule can feel very different to another person. Use stories to prepare questions, not to set your own dose.
If you are worried about withdrawal or relapse, say so directly. Ask the prescriber to explain the tradeoffs, alternatives, and follow-up plan in language you understand. You can request a slower discussion or a second clinical opinion if you remain uncertain, while still seeking urgent help for severe symptoms.
Bottom line
After a citalopram dose change, discontinuation symptoms and returning depression can overlap, and timing alone cannot distinguish them. Do not stop abruptly, create a taper yourself, or double a missed dose. Contact the prescriber with a brief timeline, the exact medicine and schedule, and changes in mood or functioning. Suicidal thoughts or immediate danger require urgent crisis or emergency support.
Sources and further reading
- MedlinePlus: Citalopram drug information
- DailyMed: Citalopram prescribing information
- FDA: Postmarket drug safety information for patients and providers
- 988 Suicide & Crisis Lifeline
Evidence checked October 20, 2026. General information only; do not change an antidepressant without a prescriber’s plan.